EcoDrugPlus

Potassium Voltage-Gated Channel Subfamily Q Member 3

Ensembl ID : ENSPTIG00000017927
Gene Symbol: KCNQ3
2 Cross references
191 Possible Orthologues:

Potassium Voltage-Gated Channel Subfamily Q Member 5

Ensembl ID : ENSPTIG00000011417
Gene Symbol: KCNQ5
1 Cross references
278 Possible Orthologues:

Presenilin 1

Ensembl ID : ENSPTIG00000017262
Gene Symbol: PSEN1
2 Cross references
200 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSPTIG00000010355
Gene Symbol: PSEN2
2 Cross references
205 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSPTIG00000007705
Gene Symbol: PSENEN
2 Cross references
183 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSPTIG00000018762
Gene Symbol: PTGER4
2 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSPTIG00000018492
Gene Symbol: PTGFR
2 Cross references
195 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSPTIG00000009352
Gene Symbol: PTGS1
2 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSPTIG00000017882
Gene Symbol: PTGS2
2 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSPTIG00000006030
Gene Symbol: PSMA1
2 Cross references
251 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSPTIG00000019642
Gene Symbol: PSMA2
2 Cross references
228 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSPTIG00000007709
Gene Symbol: PSMA3
2 Cross references
235 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).